The phosphoinositide 3-kinase pathway in chronic lymphocytic leukemia: Evidence for phosphatase and tensin homolog deletion on chromosome 10 deregulation

Leukemia and Lymphoma

Volumn 54, Issue 6, 2013, Pages 1123-1124

  Best, O Giles ^a   Mulligan, Stephen P ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; IDELALISIB; LACTATE DEHYDROGENASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE ZAP 70;

CANCER PROGNOSIS; CHROMOSOME 10; CHROMOSOME 10Q; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL (TOPIC); CYTOGENETICS; DNA METHYLATION; ENZYME ACTIVITY; GENE; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IGVH GENE; LEUKEMIA CELL; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PTEN GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; PTEN PHOSPHOHYDROLASE;

EID: 84877739002     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.746685     Document Type: Note

References (8)

1. Song MS, Salmena L, Pandolfi PP . The functions and regulation of the PTEN tumour suppressor . Nat Rev Mol Cell Biol 2012; 13: 283- 296.
2. Wickremasinghe RG, Prentice AG, Steele AJ . Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: Clues to the identifi cation of novel therapeutic targets. Br J Haematol 2011; 153 : 545 - 556.
3. Zou ZJ, Zhang R, Fan L, et al . Low expression level of phosphatase and tensin homolog deleted on chromosome ten predicts poor prognosis in chronic lymphocytic leukemia . Leuk Lymphoma 2013;54 : 1159 - 1164.
4. Novak U, Oppliger Leibundgut E, Hager J, et al . A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL) . Blood 2002; 100 : 1787 - 1794.
5. Leupin N, Cenni B, Novak U, et al . Disparate expression of the PTEN gene: A novel fi nding in B-cell chronic lymphocytic leukaemia (B-CLL) . Br J Haematol 2003; 121 : 97 - 100.
6. Yamanaka Y, Tagawa H, Takahashi N, et al . Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia . Blood 2009; 114 : 3265 - 3275.
7. Ross AH, Gericke A . Phosphorylation keeps PTEN phosphatase closed for business . Proc Natl Acad Sci USA 2009; 106 : 1297 - 1298.
8. Furman RR, Byrd JC, Brown JR, et al . CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110{delta}, demonstrates clinical activity and pharmacodynamic eff ects in patients with relapsed or refractory chronic lymphocytic leukemia. Blood 2010 ; 116(Suppl. 1) : Abstract 55.